Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13

Benzinga · 1d ago
Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.